Gefitinib

Product NDC
67184-0531
11-digit product format
671840531
Labeler code
67184
Product ID
67184-0531_8aa73f33-2813-4dfa-939f-e4291081449a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gefitinib
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Qilu Pharmaceutical Co., Ltd.
Application
ANDA211591
Marketing category
ANDA
Marketing start
2023-02-13
Substance
GEFITINIB
Active strength
250 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A211591-001GEFITINIBGEFITINIB250MGTABLET / ORALAB2023-02-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A211591-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-138072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-136a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-131c564ffb4f44…
2023-12-20 04:57 UTC2023-12A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-139b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-133f0d92c62455…
2023-05-13 08:27 UTC2023-05A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211591-001GEFITINIB250MGTABLET / ORALAB2023-02-13a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A211591-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A211591-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A211591-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A211591-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A211591-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A211591-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A211591-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A211591-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A211591-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A211591-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A211591-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A211591-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A211591-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A211591-001AB18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A211591-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A211591-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A211591-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A211591-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A211591-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A211591-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A211591-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A211591-001AB1053a50430f4f…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A211591-001AB1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Gefitinib
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GEFITINIB250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
S65743JHBSInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
349472Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0afc12dd-12f8-4def-9027-f38412a862b9Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
15910139-bf2a-487e-8f21-64569f704efcProduct name320260304
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
d723478e-ad4a-ec23-6bd7-cfe33e1e3840Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67184-0531-1Gefitinib30 in 1 BOTTLETABLET, COATED307
67184-0531-2Gefitinib500 in 1 BOTTLETABLET, COATED5007
67184-0531-3Gefitinib3 in 1 CARTONTABLET, COATED37
67184-0531-3Gefitinib10 in 1 BLISTER PACKTABLET, COATED107

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67184-0531GEFITINIB TABLET, COATED [QILU PHARMACEUTICAL CO., LTD.]7Current NDC, 4 package rows20230223_0afc12dd-12f8-4def-9027-f38412a862b9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GefitinibGEFITINIBIngenus Pharmaceuticals, LLC6402435f-9f6a-4f02-91a2-6267d783fa782023-12-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211591
application number: ANDA211591
GefitinibGEFITINIBQilu Pharmaceutical Co., Ltd.0afc12dd-12f8-4def-9027-f38412a862b92023-02-22Warnings, Adverse reactionsExact identifier
application applno (ANDA): 211591
application number: ANDA211591
ndc (product): 67184-0531

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
349472gefitinib 250 MG Oral TabletPSN0afc12dd-12f8-4def-9027-f38412a862b97
349472gefitinib 250 MG Oral TabletSCD0afc12dd-12f8-4def-9027-f38412a862b97

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67184-0531-16718405310130 TABLET, COATED in 1 BOTTLE (67184-0531-1) 2023-02-13NoNoCurrent
67184-0531-267184053102500 TABLET, COATED in 1 BOTTLE (67184-0531-2) 2023-02-13NoNoCurrent
67184-0531-3671840531033 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK3 blister pack2023-02-13NoNoCurrent